Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Siwani Makmur Tbk (SIMA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Siwani Makmur Tbk: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Siwani Makmur Tbk diperdagangkan di Rp50 (kapitalisasi pasar 22,13 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Siwani Makmur Tbk. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SIMA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 22,13 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Siwani Makmur Tbk
PT Siwani Makmur Tbk (the Company) was established under the name PT Super Indah Makmur based on Notarial Deed No. 43 dated June 7, 1985 of Wiryomartani, SH. On September 23, 1996 its changed the name to be PT Van Der Horst Indonesia, Tbk, and on February 20, 2001, it changed again its named to be PT Siwani Makmur, Tbk.
Selengkapnya di halaman SIMA →
